None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Over 20 years old 2) Subjects with benign paroxysmal positional vertigo 3) Subjects who do not show any other neurological abnormalities. 4) Subjects who agree to participate in this clinical trial.
Exclusion criteria
Exclusion criteria: 1) Subjects with the progressive neurological diseases. 2) According to the opinions of the investigator, to participate in this clinical trial is a serious danger to the well-being of subjects or may result in unreliable outcome at the end of the study. 3) Subjects with severe, acute, chronic, progressive or degenerative diseases that may affect this clinical trial. 4) Subjects that are not able to use a web-based program due to his/her cognitive abilities. 5) Subjects who disagree with this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effectiveness of treatment for the recurrent of benign paroxysmal positional vertigo. | — |
Secondary
| Measure | Time frame |
|---|---|
| Type of benign paroxysmal positional vertigo;Affected ear;Duration until recurrence;The difficulty of using the web-based program | — |
Countries
Korea, Republic of
Contacts
Seoul National University Bundang Hospital